Type of Adjuvant Endocrine Therapy and Disease-Free Survival in Patients With Early HR+/HER2+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
NPJ breast cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial
NPJ Breast Cancer 2023 Feb 04;9(1)6, MV Dieci, G Bisagni, S Bartolini, A Frassoldati, R Vicini, S Balduzzi, R D'amico, P Conte, V GuarneriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.